| abstract |
Preparation for the treatment of interferon-sensitive infectious diseases for use in human and veterinary medicine, characterized by the fact that it contains as active principle a fowl pox virus which has been attenuated by 420 to 800 cell culture passages, optionally together with a pharmaceutical excipient or adjuvant, preferably containing a sufficient number of virus units so as to provide a total of 10 8 to 10 10 virus units per treatment involving 2 to 6 administrations thereof, method for the production thereof, method of producing pharmaceutical forms thereof, the pharmaceutical forms themselves, and a method of growing an effective fowl pox virus for use in the preparations of the invention. |